Performance of a new-generation chemiluminescent assay for hepatitis B surface antigen

Clinical Chemistry

Volumn 52, Issue 8, 2006, Pages 1592-1598

  Chen, Dan ^a,c   Kaplan, Lawrence A ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; DEVICE; ENZYME IMMUNOASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; NONHUMAN; PERFORMANCE; POLYMERASE CHAIN REACTION; SERODIAGNOSIS; VIRUS LOAD;

BIOLOGICAL MARKERS; CHEMILUMINESCENT MEASUREMENTS; CLINICAL CHEMISTRY TESTS; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOASSAY; NEUTRALIZATION TESTS; VIRAL LOAD;

EID: 33746652533     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.064063     Document Type: Article

References (20)

1. Lee WM. Hepatitis B infection. N Engl J Med 1997;337:1733-45.
2. Centers for Disease Control. Protection against viral hepatitis: recommendations of Immunization Practices Advisory Committee. MMWR Morbid Mortal Wkly Rep 1990;39:5-22.
3. Gitlin N. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem 1997;43:1500-6.
4. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 1985; 253:1740-5.
5. Stevens CE, Toy PT, Tong MJ, Taylor PE, Vyas GN, Nair PV, et al. Yeast-recombinant hepatitis vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257:2612-6.
6. Beasley RP, Hwang L-Y. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Dienstag JL, Hoofnagle JH, eds. Viral Hepatitis and Liver Disease. New York: Grune & Stratton, 1984:209-24.
7. Weber B, Dengler T, Berger A, Doerr HW, Rabenau H. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: Immulite HBsAg and Immulite 2000 HbsAg. J Clin Microbiol 2003;41:135-43.
8. Diagnostic Products Corporation. Immulite 2000 HBsAg assay: hepatitis B surface antigen and confirmatory test. DPC Immulite 2000 assay instructions. Los Angeles, CA: DPC, 2005.
9. Gostein MG, Aide PM, Coleman PE. Rate of hepatitis B virus infection in pregnant women determined by a monoclonal HBsAg immunoassay. J Clin Microbiol 2002;40:3493-6.
10. Centers for Disease Control. Sensitivity of the test for antibody to hepatitis B surface antigen-United States. MMWR Morbid Mortal Wkly Rep 1990 1993;42:707-10.
11. Diagnostic Products Corporation. Immulite 2000 anti-HBs assay: antibody to hepatitis B surface antigen. DPC Immulite 2000 assay instructions. Los Angeles, CA: DPC, 2002.
12. Diagnostic Products Corporation. Immulite 2000 anti-HBc IgM assay: IgM antibody to hepatitis B core antigen. DPC Immulite 2000 assay instructions. Los Angeles, CA: DPC, 2002.
13. Diagnostic Products Corporation. Immulite 2000 anti-HBc total assay: total antibodies to hepatitis B core antigen. DPC Immulite 2000 assay instructions. Los Angeles, CA: DPC, 2002.
14. Ball CN, Connor-Linton J. Georgetown Linguistics Web Chi Square Calculator, http://www.georgetown.edu/faculty/ballc/webtools/web_chi.html (accessed December 2005).
15. Kahn SE, Jandreski MA. Laboratory statistics. In: Kaplan LA, Pesce AJ, Kazmierczak SC, eds. Clinical Chemistry: Theory, Analysis, Correlation, 4th ed. St. Louis, MO: Mosby, 2003:356-7.
16. Lok AS, Ghany MG, Watson G, Ayola B. Predictive value of aminotransferase and hepatitis B virus DNA levels on response to Interferon therapy for chronic hepatitis B. J Viral Hepat 1998; 5:171-8.
17. Nagata I, Colucci G, Gregorio GV, Cheeseman P, Williams R. Mieli-Vergani G, et al. The role of HBV/DNA quantitative PCR in monitoring the response to interferon treatment in chronic hepatitis B virus infection. J Hepat 1998;30:965-9.
18. Carman WF. The clinical significance of surface antigen variants of hepatitis B virus. J. Viral Hepat 1997;4(Suppl 1):11-20.
19. Chen D, Kaplan LA, Liu Q. Evaluation of two chemiluminescent immunoassays of ADVIA centaur for hepatitis B serology marker. Clin Chim Acta 2005;355:41-5.
20. Alter MJ, Kuhnert WL, Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Morbid Mortal Wkly Recomm Rep 2003;52:1-13, 15; quiz CE 1-4.